44 results
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
statement. Such statements are subject to a number of risks, uncertainties and assumptions, including those related to the impact that the COVID-19 pandemic
8-K
EX-99.1
p7enoov
21 Nov 22
Gamida Cell Provides Regulatory Update on Omidubicel
5:20pm
8-K
EX-99.1
65vi1fri8sl ar
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
m04fc0rm0and
19 Sep 22
Departure of Directors or Certain Officers
7:06am
8-K
EX-99.1
vpmbwuneuew
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
sqvwiyt8cxy5pk6pr
10 Aug 22
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase
12:00am
8-K
EX-99.1
2e8zep33rbo oyxc
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
8-K
EX-99.1
ywkw02
10 Jun 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
opsndigztez5
2 Jun 22
Gamida Cell Completes
7:31am
10-Q
kjejpimlb9kx6n64b47
12 May 22
Quarterly report
7:42am
8-K
EX-99.1
63ree9mv3s1j0cus
10 May 22
Gamida Cell Reports First Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
8d2agzye
26 Apr 22
Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201
7:30am
10-K
lru1824c 0mmzhl6ns
24 Mar 22
Annual report
7:30am
8-K
EX-99.1
lj4ds
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am